Pukhraj P Rishi MD
Retinal Disease, Ocular Oncology
Associate Professor, Truhlsen Eye Institute, University of Nebraska Medical Centre, Omaha, NE
Join to View Full Profile
Nebraska Medical Ctr# 985540Omaha, NE 68198
Phone+1 402-559-5379
Fax+1 402-559-5514
Dr. Rishi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Pukhraj Rishi is an ophthalmologist in Omaha, NE and is affiliated with Nebraska Medicine - Nebraska Medical Center. He received his medical degree from B. J. Medical College Ahmedabad and has been in practice 29 years. He specializes in retinal disease and ocular oncology and is experienced in retinoblastoma, retina surgery, ophthalmic oncology, and pediatric retinal disease. He has more than 200 publications.
Education & Training
University of Nebraska Medical Center College of MedicineFellowship, Surgical Retina and Vitreous, 2020 - 2021
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Ocular Oncology/Ophthalmic Pathology, 2012 - 2013
B. J. Medical College AhmedabadClass of 1995
Certifications & Licensure
NE State Medical License 2021 - 2026
Awards, Honors, & Recognition
- Achievement Award American Academy of Ophthalmology, 2024
- International Education award American Academy of Ophthalmology, 2020
- Honor award American Society of Retina Specialists (ASRS), 2020
Clinical Trials
- To Study the Effects of Refractive Surgery on OCT Measurements in the Eye Start of enrollment: 2024 Jun 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsInflammation and Occlusive Retinal Vasculitis Post Faricimab.Will Bruening, Sean Kim, Steven Yeh, Pukhraj Rishi, Christopher D Conrady
JAMA Ophthalmology. 2025-03-01 - Low-Dose Bevacizumab 0.03 mg for Treatment of Type 1 Retinopathy of Prematurity.Thomas W Hejkal, Shruti Sinha, Pukhraj Rishi, Samiksha F Jain, Paul J Rychwalski
Ophthalmology. Retina. 2025-02-12 - A growing pigmented iris lesion in a middle-aged white woman.Marc Ohlhausen, Pukhraj Rishi
Digital Journal of Ophthalmology. 2025-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
